Direct Radiofrequency Ablation of Portal Vein Tumor Thrombus in Continuity with Hepatocellular Carcinoma

Thanos, Loukas; Sotiropoulou, Evangelia; Tanteles, Savvas; Pomoni, Maria; Kelekis, Dimitrios

doi:10.1016/j.jvir.2009.10.034

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2011

2018

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other studies have shown benefit with percutaneous direct intratumoral RF of tumor thrombosis in the portal circulation. Thanos et al [18] reported direct RF ablation of portal vein tumor thrombus in continuity with hepatocellular carcinoma and observed patency of the portal vein 16 months after RF ablation. Likewise, Giorgio et al [19] discussed the merit of percutaneous RF ablation of both the HCC nodule and the portal vein tumor thrombus and concluded that this approach has high efficacy and safety and a low rate of complications.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous Management of Portal Vein Patency and Integrity Problems - Catheter Directed Local Thrombolysis, Stenting, Endoluminal RFA & Angioplasty by Balloon or Stenting

Mizandari¹,

Habib²

2016

ujmsj

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Percutaneous Management of Portal Vein Patency and Integrity Problems - Catheter Directed Local Thrombolysis, Stenting, Endoluminal RFA & Angioplasty by Balloon or Stenting

Mizandari¹,

Habib²

2016

ujmsj

View full text Add to dashboard Cite

Novel Percutaneous Radiofrequency Ablation of Portal Vein Tumor Thrombus: Safety and Feasibility

Mizandari

Zhang

et al. 2012

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

Intra-caval Percutaneous Radiofrequency Ablation for a Neuroendocrine Tumor (NET) Metastasis in Transplanted Liver

Ierardi

Biondetti

Padovano

et al. 2018

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

Less than 1% of patients with liver metastases from neuroendocrine tumors (NETs) are susceptible to liver transplantation. We report a case of a patient transplanted 13 years ago for NET metastases, with a lesion histologically proved for NET metastasis located at the cava vein anastomosis. He was treated with percutaneous radiofrequency ablation (RFA) after a first failed attempt of endovascular approach. The vascular heat sink, which RFA is susceptible to, was considered an advantage in this case, since it restricted the propagation of heat only to the tissue located in the very proximity of the RFA antenna, protecting the inferior vena cava vessel walls. This positive result may suggest an additional use of RFA in selected challenging cases.

show abstract

Direct Radiofrequency Ablation of Portal Vein Tumor Thrombus in Continuity with Hepatocellular Carcinoma

Cited by 5 publications

References 12 publications

Percutaneous Management of Portal Vein Patency and Integrity Problems - Catheter Directed Local Thrombolysis, Stenting, Endoluminal RFA & Angioplasty by Balloon or Stenting

Percutaneous Management of Portal Vein Patency and Integrity Problems - Catheter Directed Local Thrombolysis, Stenting, Endoluminal RFA & Angioplasty by Balloon or Stenting

Novel Percutaneous Radiofrequency Ablation of Portal Vein Tumor Thrombus: Safety and Feasibility

Intra-caval Percutaneous Radiofrequency Ablation for a Neuroendocrine Tumor (NET) Metastasis in Transplanted Liver

Contact Info

Product

Resources

About